The education of new investigators is essential to our progress in the prevention, detection, diagnosis, and treatment of cancer. The Tumor Biology Training Program provides a comprehensive curriculum for the career development of pre- and postdoctoral trainees interested in basic as well as clinical approaches to cancer research. A central feature of the program is its strong cancer focus and its clinical-translational interactions. State-of-the-art cancer research training is available in the laboratories of the participating faculty, while formal courses, seminars, journal clubs, and special interests group meetings contribute to a distinctly interdisciplinary educational experience. Over the past 5 years, the Tumor Biology Ph.D. Training Program has made significant advances. We have become a degree-granting program, allowing us to focus our training specifically on cancer and take full advantage of the basic and clinical resources of the Lombardi Cancer Center. Our faculty have developed more than a dozen cancer-specific new courses for this training program, and continue to do so. We have incorporated significant exposure to clinical concepts through courses, trainee involvement in weekly clinical conferences and seminars, and through monthly Oncology Grand Rounds that focus on translational cancer research. As our reputation has grown, so has our program, and each year we attract a larger pool of ever more qualified candidates. The T32 grant has allowed us to recruit the best possible candidates and provide them with excellent formal and laboratory training, as well as career guidance and development opportunities. While the Tumor Biology Training Program has in the past been exclusively a predoctoral training program, we now propose over the next five years to progressively add a postdoctoral component, that will make use of the numerous resources we have developed for our Ph.D. training program. The continued support of this program will allow us to maintain our mission of providing predoctoral and postdoctoral trainees with a broad perspective on cancer research and preparing them for successful careers in the battle against this disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009686-06
Application #
6452891
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1996-07-01
Project End
2004-05-31
Budget Start
2002-06-01
Budget End
2003-05-31
Support Year
6
Fiscal Year
2002
Total Cost
$320,879
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lelo, Alana; Prip, Frederik; Harris, Brent T et al. (2018) STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer. Clin Cancer Res 24:4145-4153
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Vera, Nicholas B; Chen, Zhidan; Pannkuk, Evan et al. (2018) Differential mobility spectrometry (DMS) reveals the elevation of urinary acetylcarnitine in non-human primates (NHPs) exposed to radiation. J Mass Spectrom 53:548-559
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Tassi, Elena; Lai, En Yin; Li, Lingli et al. (2018) Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein). Hypertension 71:160-167
Speidell, Andrew P; Demby, Tamar; Lee, Yichien et al. (2018) Development of a Human APOE Knock-in Mouse Model for Study of Cognitive Function After Cancer Chemotherapy. Neurotox Res :
Pannkuk, Evan L; Laiakis, Evagelia C; Fornace Jr, Albert J et al. (2018) A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation. Health Phys 115:3-11
Tricoli, Lucas; Berry, Deborah L; Albanese, Chris (2017) A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation. J Vis Exp :
Prentice, Ross L; Aragaki, Aaron K; Van Horn, Linda et al. (2017) Low-fat dietary pattern and cardiovascular disease: results from the Women's Health Initiative randomized controlled trial. Am J Clin Nutr 106:35-43

Showing the most recent 10 out of 214 publications